Search results for "Mycobacterium"

showing 10 items of 212 documents

Chronic Infiltrates and Persisting Ulcerations on the Arms and Legs—Quiz Case

2005

Pathologymedicine.medical_specialtybiologybusiness.industryMedicineDermatologyGeneral Medicinebusinessbiology.organism_classificationMycobacterium haemophilumArchives of Dermatology
researchProduct

Severe tuberculous meningoencephalitis in a 30-year old woman with active systemic lupus erythematosus.

1997

Tuberculosis is a significant cause of morbidity and mortality in immunocompromising diseases such as systemic lupus erythematosus (SLE). It often is difficult to distinguish between central nervous system (CNS) involvement and infectious complications in SLE. We report the case of a 30-year-old woman with active SLE and severe tuberculous meningoencephalitis. The diagnosis of tuberculous meningoencephalitis was confirmed by cerebrospinal fluid culture examination, which revealed mycobacterium tuberculosis and typical findings for tuberculous meningoencephalitis on magnetic resonance imaging. Despite treatment with isoniazid, rifampicin, ethambutol, streptomycin, and prednisone, the patient…

Pediatricsmedicine.medical_specialtyTuberculosisbiologybusiness.industryIsoniazidmedicine.diseasebiology.organism_classificationTuberculous meningitisMycobacterium tuberculosisRheumatologyPrednisoneMedicineskin and connective tissue diseasesbusinessRifampicinEthambutolmedicine.drugAnti-SSA/Ro autoantibodiesJournal of clinical rheumatology : practical reports on rheumaticmusculoskeletal diseases
researchProduct

New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method

2003

Objectives: In order to select new drugs and to predict their in vitro activity against Mycobacterium avium complex (MAC), new quantitative structure-activity relationship (QSAR) models were developed. Methods: The activities against MAC of 29 structurally heterogeneous drugs were examined by means of linear discriminant analysis (LDA) and multilinear regression analysis (MLRA) by using topological indices (TI) as structural descriptors. In vitro antimycobacterial activities were determined by a broth microdilution method with 7H9 medium. Results: The topological model obtained successfully classifies over 80% of compounds as active or inactive; consequently, it was applied in the search fo…

PharmacologyMicrobiology (medical)Virtual screeningQuantitative structure–activity relationshipbiologymedicine.drug_classBroth microdilutionQuantitative Structure-Activity RelationshipMicrobial Sensitivity TestsComputational biologyMycobacterium avium Complexbiology.organism_classificationLinear discriminant analysisAntimycobacterialModels BiologicalIn vitroAnti-Bacterial AgentsMicrobiologyInfectious DiseasesDrug DesignmedicinePharmacology (medical)Mycobacterium avium complexMolecular topologyJournal of Antimicrobial Chemotherapy
researchProduct

Epidemiology of Mycobacterial Resistance(Especially <i>Mycobacterium tuberculosis</i>)

1999

Pharmacologymedicine.medical_specialtyTuberculosisbiologymedicine.drug_classbusiness.industryAntibioticsGeneral Medicinebiology.organism_classificationmedicine.diseaseMicrobiologyMycobacterium tuberculosisInfectious DiseasesOncologyDrug DiscoveryEpidemiologyImmunologymedicinePharmacology (medical)businessAntibacterial agentChemotherapy
researchProduct

Comparative Proteomics of Activated THP-1 Cells Infected with Mycobacterium tuberculosis Identifies Putative Clearance Biomarkers for Tuberculosis Tr…

2015

Biomarkers for determining clearance of Mycobacterium tuberculosis (Mtb) infection during anti-tuberculosis therapy or following exposure could facilitate enhanced monitoring and treatment. We screened for biomarkers indicating clearance of Mtb infection in vitro. A comparative proteomic analysis was performed using GeLC MSI/MS. Intracellular and secreted proteomes from activated THP-1 cells infected with the Mtb H37Rv strain (MOI = 1) and treated with isoniazid and rifampicin for 1 day (infection stage) and 5 days (clearance stage) were analyzed. Host proteins associated with early infection (n = 82), clearance (n = 121), sustained in both conditions (n = 34) and suppressed by infection (n…

ProteomicsProteomeCell Line Tumorlcsh:Rlcsh:MedicineHumansTuberculosislcsh:QMycobacterium tuberculosislcsh:ScienceBiomarkersResearch ArticlePloS one
researchProduct

Permanent Loss of Human Leukocyte Antigen E–restricted CD8+ T Stem Memory Cells in Human Tuberculosis

2022

Pulmonary and Respiratory MedicineHLA AntigensHLA-EClinical BiochemistryTuberculosisMycobacterium tuberculosisStem cellsCell BiologyCD8-Positive T-LymphocytesMolecular BiologyAmerican Journal of Respiratory Cell and Molecular Biology
researchProduct

Host-directed therapies and holistic care for tuberculosis

2020

Pulmonary and Respiratory Medicinemedicine.medical_specialtyTuberculosisbusiness.industryAntitubercular AgentsMEDLINEHolistic HealthMycobacterium tuberculosisHolistic healthmedicine.diseaseHost-Pathogen InteractionsTuberculosis Multidrug-ResistantmedicineHumansIntensive care medicinebusinessHost (network)The Lancet Respiratory Medicine
researchProduct

Serological biomarkers for the diagnosis of Mycobacterium abscessus infections in cystic fibrosis patients

2021

International audience; Background: Culture conditions sometimes make it difficult to detect non-tuberculous mycobacteria (NTM), particularly Mycobacterium abscessus, an emerging cystic fibrosis (CF) pathogen. The diagnosis of NTM positive cases not detected by classical culture methods might benefit from the development of a serological assay.Methods: As part of a diagnostic accuracy study, a total of 173 sera CF-patients, including 33 patients with M. abscessus positive cultures, and 31 non-CF healthy controls (HC) were evaluated. Four M. abscessus antigens were used separately, comprising two surface extracts (Interphase (INP) and a TLR2 positive extract (TLR2eF)) and two recombinant pro…

Pulmonary and Respiratory Medicinemedicine.medical_specialty[SDV]Life Sciences [q-bio]Mycobacterium Infections NontuberculousMycobacterium abscessusCystic fibrosisGastroenterologyCystic fibrosisSerology03 medical and health sciences0302 clinical medicineAntigenInternal medicineNon-tuberculous mycobacteriamedicineHumans030212 general & internal medicinePathogenComputingMilieux_MISCELLANEOUSSerodiagnosisMycobacterium abscessusbiologybusiness.industryAntibody titerNontuberculous Mycobacteriamedicine.diseasebiology.organism_classificationbacterial infections and mycoses3. Good healthMycobacterium abscessus InfectionsSerology030228 respiratory systemSerological biomarkersPediatrics Perinatology and Child HealthELISAbusinessBiomarkers
researchProduct

Human leucocyte antigen-A2 restricted and Mycobacterium tuberculosis 19-kDa antigen-specific CD8+ T-cell responses are oligoclonal and exhibit a T-ce…

2001

CD8+ T cells can be grouped into two different types of secretory T lymphocytes, based on the cytokine-secretion pattern upon antigen exposure: those with a T-cell cytotoxic type 1 response (Tc1), which secrete interferon-gamma (IFN-gamma), or those with a T-cell cytotoxic type 2 response, which secrete interleukin (IL)-4 and IL-10. We examined the CD8+ T-cell response directed against an immunodominant human leucocyte antigen (HLA)-A2-presented peptide derived from a 19-kDa Mycobacterium tuberculosis-associated antigen. T cells were examined by functional analysis and by T-cell receptor (TCR) complementarity-determining region 3 (CDR3)-spectratyping, which defines the complexity of a T-cel…

Receptors Antigen T-Cell alpha-betaT cellImmunologyHuman leukocyte antigenCD8-Positive T-LymphocytesBiologyLymphocyte ActivationEpitopeCell LineInterferon-gammaAntigenHLA-A2 AntigenmedicineHumansImmunology and AllergyCytotoxic T cellAntigen-presenting cellTuberculosis PulmonaryAntigens BacterialImmunodominant EpitopesT-cell receptorGranulocyte-Macrophage Colony-Stimulating FactorMycobacterium tuberculosisOriginal ArticlesComplementarity Determining RegionsMolecular biologyPeptide FragmentsClone Cellsmedicine.anatomical_structureImmunologyInterleukin-4CD8Immunology
researchProduct

RUOLO DEI "RECETTORI ATIPICI" PER CITOCHINE E CHEMOCHINE, TIR8 E D6, NELLA REGOLAZIONE DELLE RISPOSTE INFIAMMATORIE INDOTTE DA MYCOBACTERIUM TUBERCUL…

2011

Settore MED/04 - Patologia GeneraleMYCOBACTERIUM TUBERCULOSISINFIAMMATORIERECETTORI ATIPICICHEMOCHINETIR8 E D6CITOCHINE
researchProduct